Stay updated on Rucaparib+Enzalutamide vs Enzalutamide in Metastatic Prostate Ca Clinical Trial
Sign up to get notified when there's something new on the Rucaparib+Enzalutamide vs Enzalutamide in Metastatic Prostate Ca Clinical Trial page.

Latest updates to the Rucaparib+Enzalutamide vs Enzalutamide in Metastatic Prostate Ca Clinical Trial page
- Check2 days agoChange DetectedA new revision entry v3.5.3 was added to the record history, and the previous v3.5.2 entry was removed from the listing. This updates the page's revision history to reflect the latest versioning of the record.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe record history adds a new site revision entry v3.5.2 and removes the older revision entry v3.5.0.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded revision v3.5.0 and deleted revision v3.4.3 from the history listing.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.4.3 was added to the study record history, and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check74 days agoChange DetectedA minor revision update is shown: from Revision: v3.4.1 to v3.4.2 in the history section, with no changes to study data or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded version v3.4.1 for the CASPAR study with updates to Contacts/Locations, Conditions, Oversight, Study Status, and Study Identification. The older funding notice (v3.4.0, 2025-01-15) was removed.SummaryDifference1%

Stay in the know with updates to Rucaparib+Enzalutamide vs Enzalutamide in Metastatic Prostate Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib+Enzalutamide vs Enzalutamide in Metastatic Prostate Ca Clinical Trial page.